Vigilant: An Engineered VirD2-Cas9 Complex for Lateral Flow Assay-Based Detection of SARS-CoV2

[Image: see text] Rapid, sensitive, and specific point-of-care testing for pathogens is crucial for disease control. Lateral flow assays (LFAs) have been employed for nucleic acid detection, but they have limited sensitivity and specificity. Here, we used a fusion of catalytically inactive SpCas9 en...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsic, Tin, Ali, Zahir, Tehseen, Muhammad, Mahas, Ahmed, Hamdan, Samir, Mahfouz, Magdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056947/
https://www.ncbi.nlm.nih.gov/pubmed/33844549
http://dx.doi.org/10.1021/acs.nanolett.1c00612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056947/
https://www.ncbi.nlm.nih.gov/pubmed/33844549
http://dx.doi.org/10.1021/acs.nanolett.1c00612

Ejemplares similares